JP2003501345A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501345A5
JP2003501345A5 JP2000594482A JP2000594482A JP2003501345A5 JP 2003501345 A5 JP2003501345 A5 JP 2003501345A5 JP 2000594482 A JP2000594482 A JP 2000594482A JP 2000594482 A JP2000594482 A JP 2000594482A JP 2003501345 A5 JP2003501345 A5 JP 2003501345A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
vegf
composition according
growth factor
vascular endothelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594482A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501345A (ja
Filing date
Publication date
Priority claimed from US09/234,591 external-priority patent/US6706682B2/en
Application filed filed Critical
Publication of JP2003501345A publication Critical patent/JP2003501345A/ja
Publication of JP2003501345A5 publication Critical patent/JP2003501345A5/ja
Pending legal-status Critical Current

Links

JP2000594482A 1999-01-21 2000-01-21 勃起不全の治療における血管内皮成長因子の使用 Pending JP2003501345A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/234,591 US6706682B2 (en) 1999-01-21 1999-01-21 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
US09/234,591 1999-01-21
PCT/US2000/001535 WO2000043029A1 (en) 1999-01-21 2000-01-21 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction

Publications (2)

Publication Number Publication Date
JP2003501345A JP2003501345A (ja) 2003-01-14
JP2003501345A5 true JP2003501345A5 (enExample) 2007-03-08

Family

ID=22882011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594482A Pending JP2003501345A (ja) 1999-01-21 2000-01-21 勃起不全の治療における血管内皮成長因子の使用

Country Status (9)

Country Link
US (2) US6706682B2 (enExample)
EP (1) EP1150698B1 (enExample)
JP (1) JP2003501345A (enExample)
AT (1) ATE303818T1 (enExample)
AU (1) AU2623700A (enExample)
CA (1) CA2360058A1 (enExample)
DE (1) DE60022478T2 (enExample)
DK (1) DK1150698T3 (enExample)
WO (1) WO2000043029A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706682B2 (en) * 1999-01-21 2004-03-16 The Trustees Of Columbia University In The City Of New York Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
CA2386480A1 (en) * 1999-10-01 2001-04-12 Julie M. Miller A method of treating erectile dysfunction
US20020032153A1 (en) * 2000-03-10 2002-03-14 Whitehouse Martha Jo Methods and compositions for the treatment and prevention of erectile dysfunction
EP1365794A2 (en) * 2000-07-21 2003-12-03 Lue, Tom Prevention and treatment of sexual arousal disorders
US7223406B2 (en) 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2007138590A2 (en) * 2006-05-30 2007-12-06 Yossi Gross Implantable pump for drug delivery to treat erectile dysfunction
US8152711B2 (en) * 2007-03-21 2012-04-10 Yossi Gross Implantable peristaltic pump to treat erectile dysfunction
US7818062B2 (en) * 2008-01-31 2010-10-19 Ed Tech Medical Ltd. Peristaltic pump for treatment of erectile dysfunction
US20120183519A1 (en) * 2011-01-13 2012-07-19 Biomet Biologics, Llc Treatment of erectile dysfunction using platelet-rich plasma
WO2016112049A1 (en) 2015-01-06 2016-07-14 Cardiovascular Biotherapeutics, Inc. Angiogenic treatment of ischemic heart disease
CA2976675A1 (en) * 2015-02-16 2016-08-25 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236904A (en) 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5652225A (en) * 1994-10-04 1997-07-29 St. Elizabeth's Medical Center Of Boston, Inc. Methods and products for nucleic acid delivery
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
WO1999056785A2 (en) 1998-05-01 1999-11-11 University Of Pittsburgh Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction
AU4077499A (en) 1998-05-15 1999-12-06 Glaxo Group Limited Infrared thermography
US6706682B2 (en) * 1999-01-21 2004-03-16 The Trustees Of Columbia University In The City Of New York Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
CA2386480A1 (en) 1999-10-01 2001-04-12 Julie M. Miller A method of treating erectile dysfunction

Similar Documents

Publication Publication Date Title
US6037346A (en) Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
AU734734B2 (en) Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
JP2003501345A5 (enExample)
AR046485A1 (es) Sistema de administracion para drogas y terapia celular
CA2352552A1 (en) Treatment of erectile dysfunction
JP2001502659A (ja) 勃起機能障害の治療のための併用療法
EA200001043A2 (ru) Соединения для лечения женской сексуальной дисфункции
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
PT1782825E (pt) Tratamento de doenças de armazenanto de glicogénio tipo ii
JP2005537234A5 (enExample)
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
NZ569331A (en) COP 1 for treatment of inflammatory bowel diseases
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
JP2004537500A5 (enExample)
WO2005011618A3 (en) Methods for the treatment of male and female sexual dysfunction
JP2002530353A5 (enExample)
DK1150698T3 (da) Anvendelser af vaskulær endotelvækstfaktor i behandlingen af erektil dysfunktion
WO2000023126A3 (en) Methods for treating superficial bladder carcinoma
Shinn-Nan Lin et al. Role of Cyclic Adenosine Monophosphate in Prostaglandin E (1)-lnduced Penile Erection in Rabbits
EP0459377B1 (en) Use of E1 prostaglandin to cure male erectile inpotence
EE04966B1 (et) (-)-5-(3-klorofenl)-alfa-(4-klorofenl)-alfa-(1-metl-1H-imidasool-5-l)tetrasolo -[1,5-a]kinasoliin-7-metaanamiin, selle valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetodselle valmistamiseks
Dinsmore Available and future treatments for erectile dysfunction
JP2000178203A5 (enExample)
AR062894A1 (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths)
Fu et al. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients